We sought to investigate the role of Bv8 down-regulation as a consensus target of DmiR 1-3 expression in A-GBM tumors by analyzing the mobilization and tumor recruitment of bone marrow-derived CD11b+ and Gr1+ myeloid cells. The gene discussed is PROK2; the disease is glioblastoma.